BR9302643A - Compostos,seu processo de preparacao,seu uso e composicao farmaceutica - Google Patents
Compostos,seu processo de preparacao,seu uso e composicao farmaceuticaInfo
- Publication number
- BR9302643A BR9302643A BR9302643A BR9302643A BR9302643A BR 9302643 A BR9302643 A BR 9302643A BR 9302643 A BR9302643 A BR 9302643A BR 9302643 A BR9302643 A BR 9302643A BR 9302643 A BR9302643 A BR 9302643A
- Authority
- BR
- Brazil
- Prior art keywords
- radical
- cycloalkyl
- alkyl
- phenyl
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR929207736A FR2692893B1 (fr) | 1992-06-24 | 1992-06-24 | Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9302643A true BR9302643A (pt) | 1994-01-11 |
Family
ID=9431129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9302643A BR9302643A (pt) | 1992-06-24 | 1993-06-24 | Compostos,seu processo de preparacao,seu uso e composicao farmaceutica |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US5464847A (pt) |
| EP (1) | EP0576350B1 (pt) |
| JP (1) | JPH0656809A (pt) |
| KR (1) | KR100228813B1 (pt) |
| CN (1) | CN1035552C (pt) |
| AT (1) | ATE159721T1 (pt) |
| AU (1) | AU665256B2 (pt) |
| BR (1) | BR9302643A (pt) |
| CA (1) | CA2099062A1 (pt) |
| CZ (1) | CZ125293A3 (pt) |
| DE (1) | DE69314855T2 (pt) |
| DK (1) | DK0576350T3 (pt) |
| ES (1) | ES2110070T3 (pt) |
| FI (1) | FI932909A (pt) |
| FR (1) | FR2692893B1 (pt) |
| GR (1) | GR3025684T3 (pt) |
| HK (1) | HK1002632A1 (pt) |
| HU (1) | HUT66384A (pt) |
| IL (1) | IL106088A (pt) |
| IS (1) | IS4040A (pt) |
| MX (1) | MX9303770A (pt) |
| MY (1) | MY109557A (pt) |
| NO (1) | NO303118B1 (pt) |
| NZ (1) | NZ247949A (pt) |
| PH (1) | PH30921A (pt) |
| PL (2) | PL176103B1 (pt) |
| RU (1) | RU2102389C1 (pt) |
| SG (1) | SG50626A1 (pt) |
| SI (1) | SI9300337A (pt) |
| TW (1) | TW256834B (pt) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2714059B1 (fr) * | 1993-12-21 | 1996-03-08 | Sanofi Elf | Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
| DE4401912A1 (de) * | 1994-01-24 | 1995-07-27 | Basf Ag | Methinfarbstoffe in der nichtlinearen Optik |
| US5646152A (en) | 1994-06-15 | 1997-07-08 | Pfizer Inc. | Methods of administering CRF antagonists |
| US5795905A (en) * | 1995-06-06 | 1998-08-18 | Neurocrine Biosciences, Inc. | CRF receptor antagonists and methods relating thereto |
| FR2735777B1 (fr) * | 1995-06-21 | 1997-09-12 | Sanofi Sa | Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant |
| PT863882E (pt) | 1995-10-17 | 2002-07-31 | Janssen Pharmaceutica Nv | Pirimidinas e triazinas amino-substituidas |
| US6191131B1 (en) | 1997-07-23 | 2001-02-20 | Dupont Pharmaceuticals Company | Azolo triazines and pyrimidines |
| US6313124B1 (en) | 1997-07-23 | 2001-11-06 | Dupont Pharmaceuticals Company | Tetrazine bicyclic compounds |
| US6124289A (en) * | 1996-07-24 | 2000-09-26 | Dupont Pharmaceuticals Co. | Azolo triazines and pyrimidines |
| US6060478A (en) * | 1996-07-24 | 2000-05-09 | Dupont Pharmaceuticals | Azolo triazines and pyrimidines |
| US7094782B1 (en) | 1996-07-24 | 2006-08-22 | Bristol-Myers Squibb Company | Azolo triazines and pyrimidines |
| US5861398A (en) * | 1996-08-26 | 1999-01-19 | Alanex Corporation | Benzoperimidine-carboxylic acids and derivatives thereof |
| US6159980A (en) * | 1996-09-16 | 2000-12-12 | Dupont Pharmaceuticals Company | Pyrazinones and triazinones and their derivatives thereof |
| FR2754258B1 (fr) * | 1996-10-08 | 1998-12-31 | Sanofi Sa | Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant |
| AU6279598A (en) | 1997-02-18 | 1998-09-08 | Neurocrine Biosciences, Inc. | Biazacyclic CRF antagonists |
| PT1129096E (pt) | 1998-11-12 | 2003-09-30 | Neurocrine Biosciences Inc | Antagonistas de receptor de crf e metodos de tratamento relacionados com os mesmos |
| WO2000027846A2 (en) | 1998-11-12 | 2000-05-18 | Neurocrine Biosciences, Inc. | Crf receptor antagonists and methods relating thereto |
| US6531475B1 (en) | 1998-11-12 | 2003-03-11 | Neurocrine Biosciences, Inc. | CRF receptor antagonists and methods relating thereto |
| FR2796380B3 (fr) * | 1999-07-15 | 2001-08-17 | Sanofi Synthelabo | Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant |
| US6432989B1 (en) | 1999-08-27 | 2002-08-13 | Pfizer Inc | Use of CRF antagonists to treat circadian rhythm disorders |
| EP1149583A3 (en) * | 2000-04-13 | 2001-11-14 | Pfizer Products Inc. | Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues |
| AU2002314744A1 (en) * | 2001-04-17 | 2002-10-28 | Sepracor, Inc. | Thiazole and other heterocyclic ligands and use thereof |
| US7276526B2 (en) | 2001-07-13 | 2007-10-02 | Bristol-Myers Squibb Pharma Company | Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands |
| EP1423113A4 (en) * | 2001-08-13 | 2007-04-18 | Phenex Pharmaceuticals Ag | NR1H4 NUCLEAR RECEPTOR BINDING COMPOUNDS |
| EP1285914B1 (en) * | 2001-08-13 | 2007-12-19 | PheneX Pharmaceuticals AG | Nr1h4 nuclear receptor binding compounds |
| JP4484439B2 (ja) * | 2002-03-14 | 2010-06-16 | 国立大学法人東京工業大学 | Ｖｄａｃ調節剤 |
| AU2003213351A1 (en) * | 2002-03-14 | 2003-09-22 | Takeda Chemical Industries, Ltd. | Vdac regulator |
| DK1700856T3 (en) * | 2003-12-26 | 2015-12-14 | Kyowa Hakko Kirin Co Ltd | thiazole |
| WO2007089679A2 (en) * | 2006-02-01 | 2007-08-09 | Merck & Co., Inc. | Potassium channel inhibitors |
| ATE546437T1 (de) * | 2006-10-19 | 2012-03-15 | Hoffmann La Roche | Aminomethyl-4-imidazole |
| JP5467735B2 (ja) * | 2007-07-02 | 2014-04-09 | 東ソー株式会社 | 円筒形スパッタリングターゲット |
| IL296683B2 (en) | 2014-01-21 | 2023-12-01 | Neurocrine Biosciences Inc | Preparations for the treatment of congenital adrenal hyperplasia |
| EP3846793B1 (en) | 2018-09-07 | 2024-01-24 | PIC Therapeutics, Inc. | Eif4e inhibitors and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4264134A (en) * | 1978-05-26 | 1981-04-28 | Elliott Brothers (London) Limited | Display arrangements |
| DK150068C (da) * | 1978-06-02 | 1987-06-29 | Pfizer | Analogifremgangsmaade til fremstilling af aminothiazoler |
| US5232921A (en) * | 1987-03-12 | 1993-08-03 | Sanofi | Thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions |
| FR2612187B1 (fr) * | 1987-03-12 | 1989-07-21 | Sanofi Sa | Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant |
| FR2656610B1 (fr) * | 1989-12-29 | 1992-05-07 | Sanofi Sa | Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique. |
-
1992
- 1992-06-24 FR FR929207736A patent/FR2692893B1/fr not_active Expired - Fee Related
-
1993
- 1993-06-21 IL IL106088A patent/IL106088A/xx not_active IP Right Cessation
- 1993-06-22 EP EP93401603A patent/EP0576350B1/fr not_active Expired - Lifetime
- 1993-06-22 SG SG1996007157A patent/SG50626A1/en unknown
- 1993-06-22 AU AU41399/93A patent/AU665256B2/en not_active Ceased
- 1993-06-22 PH PH46390A patent/PH30921A/en unknown
- 1993-06-22 AT AT93401603T patent/ATE159721T1/de not_active IP Right Cessation
- 1993-06-22 ES ES93401603T patent/ES2110070T3/es not_active Expired - Lifetime
- 1993-06-22 DE DE69314855T patent/DE69314855T2/de not_active Expired - Fee Related
- 1993-06-22 NZ NZ247949A patent/NZ247949A/en unknown
- 1993-06-22 DK DK93401603T patent/DK0576350T3/da active
- 1993-06-23 NO NO932319A patent/NO303118B1/no not_active IP Right Cessation
- 1993-06-23 JP JP5152479A patent/JPH0656809A/ja active Pending
- 1993-06-23 MY MYPI93001219A patent/MY109557A/en unknown
- 1993-06-23 PL PL93321372A patent/PL176103B1/pl unknown
- 1993-06-23 SI SI9300337A patent/SI9300337A/sl unknown
- 1993-06-23 FI FI932909A patent/FI932909A/fi unknown
- 1993-06-23 MX MX9303770A patent/MX9303770A/es not_active IP Right Cessation
- 1993-06-23 HU HU9301850A patent/HUT66384A/hu unknown
- 1993-06-23 PL PL93299445A patent/PL174734B1/pl unknown
- 1993-06-23 IS IS4040A patent/IS4040A/is unknown
- 1993-06-23 US US08/080,172 patent/US5464847A/en not_active Expired - Fee Related
- 1993-06-23 CN CN93109438A patent/CN1035552C/zh not_active Expired - Fee Related
- 1993-06-23 CA CA002099062A patent/CA2099062A1/en not_active Abandoned
- 1993-06-23 RU RU93044129A patent/RU2102389C1/ru active
- 1993-06-23 CZ CZ931252A patent/CZ125293A3/cs unknown
- 1993-06-24 BR BR9302643A patent/BR9302643A/pt not_active Application Discontinuation
- 1993-06-24 KR KR1019930011709A patent/KR100228813B1/ko not_active IP Right Cessation
- 1993-08-31 TW TW082107085A patent/TW256834B/zh not_active IP Right Cessation
-
1997
- 1997-12-16 GR GR970403334T patent/GR3025684T3/el unknown
-
1998
- 1998-02-12 HK HK98101081A patent/HK1002632A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9302643A (pt) | Compostos,seu processo de preparacao,seu uso e composicao farmaceutica | |
| RU93035829A (ru) | Производные аминохинолона, замещенные арильной или гетероароматической группой, и анти-вич средства | |
| ATE124696T1 (de) | Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung. | |
| NO905519D0 (no) | Pyrimidinderivater. | |
| SE8502017D0 (sv) | 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same | |
| DE69717044D1 (de) | Flavone-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammenstellungen | |
| DE3879653D1 (de) | Virusinhibierende heterocyclische verbindungen. | |
| DK0457090T3 (da) | Fremgangsmåde til fremstilling af 3-amino-2-(het)-aroyl-acrylsyrederivater | |
| ES2084120T3 (es) | Medicamentos para prevenir y tratar enfermedades del aparato circulatorio que contienen compuestos de espiro-3-heteroazolidina. | |
| ES2065192T3 (es) | Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| DE3781044D1 (de) | Prophylaktische und heilende zusammensetzung enthaltende eine 8-chlorbenzothiazepin-verbindung und dessen verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EE | Request for examination | ||
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| TC | Change of name | ||
| FC | Decision: refusal | ||
| FC | Decision: refusal | ||
| HIFC | Refusal cancelled | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: C07D 417/12 (2006.01), C07D 277/42 (2006.0 |